BBH vs. NLR
BBH (VanEck Vectors Biotech ETF) and NLR (VanEck Uranium and Nuclear ETF) are both exchange-traded funds - BBH is a Health & Biotech Equities fund tracking the MVIS US Listed Biotech 25 Index, while NLR is a Alternative Energy Equities fund tracking the MVIS Global Uranium & Nuclear Energy Index. Both are passively managed. Over the past 10 years, BBH returned 5.75%/yr vs 13.66%/yr for NLR. At a 0.36 correlation, their price movements are largely independent. BBH charges 0.35%/yr vs 0.56%/yr for NLR.
Performance
BBH vs. NLR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BBH achieves a -1.85% return, which is significantly lower than NLR's 6.14% return. Over the past 10 years, BBH has underperformed NLR with an annualized return of 5.75%, while NLR has yielded a comparatively higher 13.66% annualized return.
BBH
- 1D
- 2.22%
- 1M
- 0.09%
- YTD
- -1.85%
- 6M
- -5.32%
- 1Y
- 23.92%
- 3Y*
- 6.14%
- 5Y*
- 0.31%
- 10Y*
- 5.75%
NLR
- 1D
- -4.59%
- 1M
- -8.11%
- YTD
- 6.14%
- 6M
- 1.51%
- 1Y
- 36.84%
- 3Y*
- 35.11%
- 5Y*
- 21.94%
- 10Y*
- 13.66%
BBH vs. NLR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BBH VanEck Vectors Biotech ETF | -1.85% | 21.18% | -4.29% | 3.94% | -15.25% | 11.81% | 22.13% | 26.34% | -10.70% | 16.46% |
NLR VanEck Uranium and Nuclear ETF | 6.14% | 56.50% | 14.26% | 36.67% | 2.29% | 13.63% | 3.49% | 0.20% | 4.94% | 8.25% |
Correlation
The correlation between BBH and NLR is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.34 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.32 |
Correlation (All Time) Calculated using the full available price history since Aug 16, 2007 | 0.36 |
The correlation between BBH and NLR shifts across timeframes, from 0.23 (1 year) to 0.36 (all time), reflecting how their relationship changes across market environments.
BBH vs. NLR - Sectors Allocation Comparison
Sectors
BBH
NLR
Healthcare
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
Financial Services
-
-
Industrials
-
Real Estate
-
-
Technology
-
Utilities
-
Healthcare
BBH
NLR
-
Basic Materials
BBH
-
NLR
-
Communication Services
BBH
-
NLR
-
Consumer Cyclical
BBH
-
NLR
-
Consumer Defensive
BBH
-
NLR
-
Energy
BBH
-
NLR
Financial Services
BBH
-
NLR
-
Industrials
BBH
-
NLR
Real Estate
BBH
-
NLR
-
Technology
BBH
-
NLR
Utilities
BBH
-
NLR
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBH vs. NLR — Risk / Return Rank
BBH
NLR
BBH vs. NLR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Biotech ETF (BBH) and VanEck Uranium and Nuclear ETF (NLR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BBH | NLR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.39 | ||
| Sortino ratioReturn per unit of downside risk | +0.45 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.17 | +0.06 |
| Calmar ratioReturn relative to maximum drawdown | 2.28 | 1.43 | +0.84 |
| Martin ratioReturn relative to average drawdown | 5.81 | 2.93 | +2.88 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BBH | NLR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.26 | 0.88 | +0.39 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.01 | 0.75 | -0.74 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.26 | 0.57 | -0.31 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.38 | 0.18 | +0.21 |
Drawdowns
BBH vs. NLR - Drawdown Comparison
The maximum BBH drawdown since its inception was -72.70%, which is greater than NLR's maximum drawdown of -65.05%. Use the drawdown chart below to compare losses from any high point for BBH and NLR.
Loading charts...
Drawdown Indicators
| BBH | NLR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -72.70% | -65.05% | -7.65% |
Max Drawdown (1Y)Largest decline over 1 year | -10.55% | -25.80% | +15.25% |
Max Drawdown (3Y)Largest decline over 3 years | -22.74% | -30.48% | +7.74% |
Max Drawdown (5Y)Largest decline over 5 years | -39.86% | -30.48% | -9.38% |
Max Drawdown (10Y)Largest decline over 10 years | -39.86% | -34.35% | -5.51% |
Current DrawdownCurrent decline from peak | -13.81% | -19.80% | +5.99% |
Average DrawdownAverage peak-to-trough decline | -20.75% | -35.72% | +14.97% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.13% | 12.61% | -8.48% |
Volatility
BBH vs. NLR - Volatility Comparison
The current volatility for VanEck Vectors Biotech ETF (BBH) is 6.06%, while VanEck Uranium and Nuclear ETF (NLR) has a volatility of 13.18%. This indicates that BBH experiences smaller price fluctuations and is considered to be less risky than NLR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BBH | NLR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.06% | 13.18% | -7.12% |
Volatility (6M)Calculated over the trailing 6-month period | 14.28% | 32.83% | -18.55% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.02% | 42.32% | -23.30% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.50% | 29.24% | -7.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.17% | 24.02% | -1.85% |
BBH vs. NLR - Expense Ratio Comparison
BBH has a 0.35% expense ratio, which is lower than NLR's 0.56% expense ratio.
Dividends
BBH vs. NLR - Dividend Comparison
BBH's dividend yield for the trailing twelve months is around 0.51%, less than NLR's 2.40% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBH VanEck Vectors Biotech ETF | 0.51% | 0.51% | 0.80% | 0.43% | 0.47% | 0.21% | 0.36% | 0.34% | 0.50% | 0.55% | 0.30% | 0.27% |
NLR VanEck Uranium and Nuclear ETF | 2.40% | 2.55% | 0.76% | 4.54% | 2.02% | 1.99% | 2.23% | 2.21% | 3.91% | 4.86% | 3.62% | 3.30% |
Frequently Asked Questions
BBH and NLR have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NLR has higher volatility (13.18%) compared to BBH (6.06%). In terms of maximum drawdown, BBH dropped -72.70% vs NLR's -65.05%.
On 10-year performance, NLR leads with 13.66% vs 5.75% for BBH. On fees, BBH is cheaper at 0.35% per year. On volatility, BBH has been the lower-risk option at 6.06%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, NLR has performed better with a 13.66% return vs 5.75%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
BBH is cheaper with a 0.35% expense ratio, compared with 0.56% for NLR.
NLR has the higher dividend yield at 2.40%, compared with 0.51% for BBH.
BBH is categorized as Health & Biotech Equities, while NLR is Alternative Energy Equities. BBH tracks MVIS US Listed Biotech 25 Index, while NLR tracks MVIS Global Uranium & Nuclear Energy Index. Their fees differ too: 0.35% for BBH and 0.56% for NLR.
BBH currently has the higher Sharpe Ratio (1.26 vs 0.88), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BBH and NLR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer